CIK 0001833214
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 853899721
- Phone
- +1 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +23,264 | 23,264 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +69,793 | 69,793 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Earnout Rights (Restricted Stock Units) | +47,777 | 47,777 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Earnout Rights (Common Stock) | +2,009,697 | 2,009,697 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +162,850 | 162,850 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +162,850 | 162,850 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +116,321 | 116,321 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Employee Stock Option (right to buy) | +23,264 | 23,264 | ||
| 2021-10-22 | HAMILTON CHRISTINE E Director | Grant or award · Earnout Rights (Restricted Stock Units) | +187,975 | 187,975 | ||
| 2021-10-22 | Pommer Jerry Lynn Chief Compliance Officer | Grant or award · Employee Stock Option (right to buy) | +69,793 | 69,793 | ||
| 2021-10-22 | Pommer Jerry Lynn Chief Compliance Officer | Grant or award · Employee Stock Option (right to buy) | +14,540 | 14,540 | ||
| 2021-10-22 | Pommer Jerry Lynn Chief Compliance Officer | Grant or award · Employee Stock Option (right to buy) | +6,979 | 6,979 | ||
| 2021-10-22 | Pommer Jerry Lynn Chief Compliance Officer | Grant or award · Earnout Rights (Restricted Stock Units) | +36,890 | 36,890 | ||
| 2021-10-22 | Randall Charles Hiram Chief Strategy Officer | Grant or award · Employee Stock Option (right to buy) | +116,321 | 116,321 | ||
| 2021-10-22 | Randall Charles Hiram Chief Strategy Officer | Grant or award · Employee Stock Option (right to buy) | +116,321 | 116,321 | ||
| 2021-10-22 | Randall Charles Hiram Chief Strategy Officer | Grant or award · Employee Stock Option (right to buy) | +116,321 | 116,321 | ||
| 2021-10-22 | Randall Charles Hiram Chief Strategy Officer | Grant or award · Employee Stock Option (right to buy) | +11,632 | 11,632 | ||
| 2021-10-22 | Randall Charles Hiram Chief Strategy Officer | Grant or award · Earnout Rights (Restricted Stock Units) | +145,681 | 145,681 | ||
| 2021-10-19 | Luke Thomas Charles Chief Medical Officer | Grant or award | +990 | $10.10 | $10K | 990 |
| 2021-10-18 | Beyer Russell P Chief Financial Officer | Grant or award | +2,475 | $10.10 | $25K | 2,475 |
Page 11 of 13 · 241 trades